Results

Total Results: 768 records

Showing results for "therapeutic".

81. Slide 1
    effectivehealthcare.ahrq.gov/sites/default/files/comparator-selection-in-observational-chapter-5.pptx
    January 01, 2013 - Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics … Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics … Effect of highly active antiretroviral therapy on incident AIDS using calendar period as an instrumental … Hormone replacement therapy and cardiovascular health in the United States. … PMID:14585769. http://www.ncbi.nlm.nih.gov/pubmed/14585769 Exposure time window Period where therapeutic

82. Evidence Summary_Comparative Effectiveness Review No. 247_Interventional Treatments for Acute and Chronic Pain: Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-247-interventional-treatments-acute-chronic-pain-evidence-summary_0.pdf
    September 01, 2021 - Evidence Summary_Comparative Effectiveness Review No. 247_Interventional Treatments for Acute and Chronic … Pain: Systematic Review Comparative Effectiveness Review Number 247 Interventional Treatments … Results The review included 37 RCTs on the comparative effectiveness of interventional therapies for … itself is associated with therapeutic benefits. … Interventional Treatments for Acute and Chronic Pain: Systematic Review.

83. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1412.pdf
    February 01, 2015 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … We have identified and are currently monitoring multiple potential therapies with these properties, … Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central … Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot

84. Dia 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/ijzerman_ahrq-webinar-mcda.pdf
    January 01, 2011 - additive value function to determine the relative preference for the alternatives: I want the best treatment … The pattern of choices reveals the implicit decision weights patients attach to therapeutic benefits … , harms, processes and costs that describe the treatment profiles (ISPOR taskforce, 2012) 5 MCDA … impact Co-payment Clinical benefit 1 3 5 7 Adverse event 1/3 1 1/3 1/5 Treatment impact 5 3 1 … impact Co-payment Clinical benefit 0.15 0.42 0.75 0.63 Adverse event 0.05 0.14 0.05 0.02 Treatment

85. Diabetes Mellitus (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1412.pdf
    January 01, 2015 - therapeutic effects and better glycemic control. … The mode of delivery, an implanted pump, is an established therapy for other drugs or other treatments … Unlike other treatments for T2DM, management of therapy with the ITCA 650 is controlled by the device … , corticosteroids, or anti-VEGF therapies, making this new intervention just another treatment option … Investigational therapeutic options in the management of DME: investigational pharmacologic treatments

86. S5 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/s5.pdf
    October 01, 2007 - The aims are to maximize the likelihood that beneficial treatments are used and that harmful treatments … misclassification), random er- ror, confounding by clinical conditions, indications for drugs, or use of other therapies … Medicaid data for research on the initiation, continuation, and patient outcomes of prescription drug therapies … Risk-adjustment esti- mates can provide information on treatment benefits for patients who received treatment … Improving depiction of benefits and harms: analyses of studies of well-known therapeutics and review

87. Psoriasis-Chronic Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_executive.pdf
    November 01, 2012 - dyslipidemia, malignancy, and teratogenicity).8,10 Phototherapy, although considered to be one of the safer therapeutic … modalities when making therapeutic decisions. … were excluded because they were determined to be irrelevant in describing the currently available therapeutic … within the biologic, nonbiologic, and phototherapy treatments. … Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities.

88. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … tracked in the system as of November 30, 2014, and pertain to very different types of diagnostic and treatment … MOMS) initiative to improve maternal health focuses on prematurity causes and interventions, obesity treatments

89. PKU Surveillance Assessment_CER 56_Low (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/phenylketonuria_surveillance.pdf
    January 15, 2013 - to the conclusions involve refinement of original estimates or do the potential changes mean some therapies … ) was identified through a brief Google search, as the original project lead suggested several new treatments … increase in Phe intake with a mean phenylalaninemia of 240±72uM, and 71±18% of Phe values within therapeutic … [sh] OR pharmaceutical preparations[mh] OR therapeutics[mh] OR diet therapy[mh] OR "diet therapy"[Subheading … Phe intake with a mean phenylalaninemia of 240±72uM and 71±18% of Phe values within therapeutic targets

90. Stroke-Atrial-Fibrillation Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/stroke-atrial-fibrillation_executive.pdf
    August 01, 2013 - Effectiveness Reviews, the program supports systematic appraisals of existing scientific evidence regarding treatments … Research for CER 119, “Treatment of Atrial Fibrillation,” focusing on the treatment of AF through rate … There are also many novel invasive treatments for AF. … , and strategies for determining longer term therapy given successful AF treatment … continued anticoagulant therapy versus bridging therapies versus interruption of therapy (i.e., stopping

91. Diabetes Mellitus (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - Many patients with T2DM do not meet treatment goals and require additional therapy with one of two … Despite combined hypoglycemic therapy, many patients with T2DM can still fail to meet treatment goals … Both treatments were generally well tolerated. … Despite combined hypoglycemic therapy, many patients with T2DM can still fail to meet treatment goals … ITCA 650 for zero-order continuous delivery of exenatide at therapeutic levels using 3-, 6-, and

92. #06 Developmental Delays ADHD, and Autism (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1506.pdf
    December 01, 2015 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … Unfortunately, these challenges translate to slow progress in developing and validating new behavioral treatments … survey available outlets for information on novel interventions and new applications of existing therapies

93. #06 Developmental Delays ADHD, and Autism (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1512.pdf
    December 01, 2015 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … This new formulation was added to the system in 2014 as a therapy in late-stage development for treating … initiative to advance patient screening timelines, automate diagnostic steps, and increase early treatment

94. Assessing Applicability: Interactive Case Study Quiz (ppt file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/assessing-applicability-quiz.ppt
    May 29, 2025 - Run-in periods can be constructed so that subjects who are tolerating therapy, are adherent to therapy … , and/or are experiencing therapeutic benefits can progress to be randomized. … In general, run-in periods eliminate subjects who will not tolerate or are not adherent to therapy. … Studies using strong methods can show that an intervention is superior to a control therapy in a study … Studies using strong methods can show that an intervention is superior to a control therapy in a study

95. Assessing Applicability: Interactive Case Study Quiz (ppt file)
    effectivehealthcare.ahrq.gov/sites/default/files/assessing-applicability-quiz.ppt
    May 29, 2025 - Run-in periods can be constructed so that subjects who are tolerating therapy, are adherent to therapy … , and/or are experiencing therapeutic benefits can progress to be randomized. … In general, run-in periods eliminate subjects who will not tolerate or are not adherent to therapy. … Studies using strong methods can show that an intervention is superior to a control therapy in a study … Studies using strong methods can show that an intervention is superior to a control therapy in a study

96. Migraine Protocol-Appendix 20111103 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine_protocol-appendix_20111103.pdf
    November 03, 2011 - OBSTRUCTIVE AIRWAY DISEASES R03DC Leukotriene receptor antagonists ATC code - The Anatomical Therapeutic … Solvay Pharmaceuticals|Nektar Therapeutics Sorlandet Hospital HF St. … The EMMES Corporation TorreyPines Therapeutics UCB, Inc. … NCT00665236 Craniosacral Therapy in Migraine: A Feasibility Study NCT00714727 Set Point Acupuncture … NCT00599586 Randomized Controlled Trial of Treating Migraine With Acupuncture NCT00901862 Magnetic Therapy

97. Dementia-Agitation-Aggression Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/dementia-agitation-aggression_executive.pdf
    March 01, 2016 - Therapeutic Touch (or Noncontact Therapeutic Touch) Therapeutic touch refers to transfers of energy … Aroma therapy with Melissa vs. no treatment/ attention control 1 (72) Insufficient – no conclusions … Light therapy vs. no treatment/attention control 4 (225) Low – agitation/aggression not improved Therapeutic … Simultaneous treatments, such as psychoactive treatments, must be accounted for. … Efficacy of music therapy treatment based on cycles of sessions: a randomised controlled trial.

98. #14 SUBSTANCE ABUSE (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1306.pdf
    June 01, 2013 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … dependency ES-3 management includes medically supervised detoxification and opiate replacement therapy … Available short-acting treatments for opioid dependence (e.g., naltrexone, methadone, buprenorphine

99. Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment in Children and Adolescents - Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/deficit-hyperactivity-protocol.pdf
    November 01, 2021 - therapies. … , digital gamified cognitive therapies, EndeavorRx, play therapy, play-based interventions, mindfulness-based … ): Specific treatments compared with other treatments as described above or to no treatment KQ 3 (monitoring … Therapies"[MeSH] OR "Combined Modality Therapy"[MeSH] ADHD Systematic Review Protocol … ] OR "alternative therapy"[tiab] OR "alternative therapies"[tiab] OR "Interpersonal skills training"

100. Disposition of Comments_Comparative Effectiveness Review No. 245: Breast Reconstruction After Mastectomy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-245-breast-reconstruction-after-mastectomy-disposition-comments.pdf
     October 01, 2021 - regarding timing of implant-based and autologous reconstruction with regard to chemotherapy and radiation therapy … reconstruction with latissimus dorsi flaps often necessitates the use of implants; (4) how timing of radiation therapy … bulk of the evidence identified in this systematic review addressed breast reconstruction after therapeutic … bulk of the evidence identified in this systematic review addressed breast reconstruction after therapeutic